What is an imaging test for prostate cancer?

CT scan: Pet scan is more useful to evaluate spread and metastasis.

Many: The common imaging tests in prostate cancer evaluation include ct and MRI of the pelvis and prostate, bone scan, pet-ct bone scan with naf-18 tracer, and rarely the prostascint test. Most cases need a basic ct scan and a bone scan.

Most only need ct: Standard work up at initial diagnosis to include gleason score derived from biopsy, psa, and clinical t stage enable us to predict the likelihood of disease spread outside the prostate capsule, to the lymph nodes, and to the bones. Based upon these risk assessments imaging should be tailored. Ct to evaluate lymph nodes, if high enough risk, bone scan to eval bones. Mri to look at capsule/lns.

Prostate cancer: If you are asking whether there is an imaging test to diagnose prostate caner, the answer is no, at least not in the curable stages. Ct, mri, nuclear scanning are all used to assess for metastatic disease once a biopsy has confirmed the diagnosis.

ProstaScint: Prostascint is a radiolabeled monoclonal antibody to prostate-specific membrane antigen. This imaging study aids in localizing sites of soft tissue metastasis in prostate cancer patients.